Isolation of Mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation

Stem Cell Reviews and Reports

Volumn 5, Issue 3, 2009, Pages 247-255

  Huang, Yong Can ^a,b   Yang, Zhi Ming ^a   Chen, Xiao He ^a   Tan, Mei Yun ^a   Wang, Jia ^a,b   Li, Xiu Qun ^a   Xie, Hui Qi ^a   Deng, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Hypoxia; Mesenchymal stem cells; Placenta; Serum deprivation

Indexed keywords

ADIPOSE TISSUE; ANOXIA; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DECIDUA; FEMALE; GENETIC MARKER; HUMAN; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PLACENTA; PREGNANCY;

ADIPOSE TISSUE; ANOXIA; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CULTURE MEDIA, SERUM-FREE; DECIDUA; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; PHENOTYPE; PLACENTA; PREGNANCY;

EID: 70349618627     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-009-9069-x     Document Type: Article

References (38)

1. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147. doi:10.1126/science.284.5411.143.
2. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93-98. doi:10.1161/hc0102.101442.
3. Haynesworth, S. E., Goshima, J., & Goldberg, V. M. (1992). Characterization of cells with osteogenic potential from human marrow. Bone, 13, 81-88. doi:10.1016/8756-3282(92)90364-3.
4. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., et al. (2002). Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Engineering, 7, 211-228. doi:10.1089/107632701300062859.
5. Zvaifler, N. J., Mutafchieva, L. M., Adams, G., Edwards, C. J., Moss, J., Burger, J. A., et al. (2000). Mesenchymal precursor cells in the blood of normal individuals. Arthritis Research, 2, 477-488. doi:10.1186/ar130.
6. Trubiani, O., Primio, R. D., Traini, T., Pizzicannella, J., Scarano, A., & Piattelli, A. (2005). Morphological and cytofluorimetric analysis of adult mesenchymal stemcells expanded ex vivo from periodontal ligament. International Journal of Immunopathology and Pharmacology, 18, 213-221.
7. Shih, D. T., Lee, D. C., Chen, S. C., Tsai, R. Y., Huang, C. T., Tsai, C. C., et al. (2005). Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells, 23, 1012-1020. doi:10.1634/stemcells.2004-0125.
8. Fehrer, C., & Lepperdinger, G. (2005). Mesenchymal stem cell aging. Experimental Gerontology, 40, 926-930. doi:10.1016/j.exger.2005.07.006.
9. In't Anker, P. S., Scherjon, S. A., Keur, C. K., de Groot-Swings, G. M. J. S., Claas, F. H. J., & Fibbe, W. E. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22, 1338-1345. doi:10.1634/stemcells.2004-0058.
10. Zhang, X. H., Mitsuru, A., Igura, K., Takahashi, K., Ichinose, S., Yamaguchi, S., et al. (2006). Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochemical and Biophysical Research Communications, 340, 944-952. doi:10.1016/j.bbrc.2005.12.091.
11. Yen, B. L., Huang, H., Chien, C. C., Jui, H. Y., Ko, B. S., Yao, M., et al. (2005). Isolation of multipotent cells from human term placenta. Stem Cells, 23, 3-9. doi:10.1634/stemcells.2004-0098.
12. Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T., & Tsuji, K. (2004). Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells, 22, 649-658. doi:10.1634/stemcells.22-5-649.
13. Cetrulo, C. L., Jr. (2006). Cord-Blood Mesenchymal Stem cells and tissue engineering. Stem Cell Reviews, 2, 163-168.
14. Chan, J., O'Donoghue, K., de la Fuente, J., Roberts, I. A., Kumar, S., Morgan, J. E., et al. (2005). Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells, 23, 93-102. doi:10.1634/stemcells.2004-0138.
15. Miao, Z. N., Jin, J., Chen, L., Zhu, J. Z., Huang, W., Zhao, J. D., et al. (2006). Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biology International, 30, 681-687. doi:10.1016/j.cellbi.2006.03.009.
16. Chien, C. C., Yen, B. L. J., Lee, F. K., Lai, T. H., Chen, Y. C., Chan, S. H., et al. (2006). In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells, 24, 1759-1768. doi:10.1634/stemcells.2005-0521.
17. Chang, C. M., Kao, C. L., Chang, Y. L., Yang, M. J., Chen, Y. C., Sung, B. L., et al. (2007). Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells. Biochemical and Biophysical Research Communications, 357, 414-420. doi:10.1016/j.bbrc.2007.03.157.
18. Parolini, O., Alviano, F., Bagnara, G. P., Bilic, G., Bühring, H. J., Evangelista, M., et al. (2008). Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells, 26, 300-311. doi:10.1634/stemcells.2007-0594.
19. Tang, J. M., Xie, Q. Y., Pan, G. D., Wang, J. N., & Wang, M. J. (2006). Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. European Journal of Cardio-Thoracic Surgery, 30, 353-361. doi:10.1016/j.ejcts.2006.02.070.
20. Morigi, M., Introna, M., Imberti, B., Corna, D., Abbate, M., Rota, C., et al. (2008). Human bone marrow-mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells, 26, 2075-2082. doi:10.1634/stemcells.2007-0795.
21. Ohnishi, S., Yanagawa, B., Tanaka, K., Miyahara, Y., Obata, H., Kataoka, M., et al. (2008). Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. Journal of Molecular and Cellular Cardiology, 42, 88-97. doi:10.1016/j.yjmcc.2006.10.003.
22. Wu, Y. J., Chen, L. W., Scott, P. G., & Tredget, E. E. (2007). Mesenchymal stem cells enhance wound healing through sifferentiation and angiogenesis. Stem Cells, 25, 2648-2659. doi:10.1634/stemcells.2007-0226.
23. Tang, Y. L., Tang, Y., Zhang, Y. C., Qian, K. P., Shen, L. P., & Phillips, M. I. (2005). Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. Journal of Molecular and Cellular Cardiology, 46, 1339-1350. doi:10.1016/j.jacc.2005.05.079.
24. Lee, O. K., Kuo, T. K., Chen, W. M., Lee, K. D., Hsieh, S. L., & Chen, T. H. (2004). Isolation of multi-potent mesenchymal stem cells from umbilical cord blood. Blood, 103, 1669-1675. doi:10.1182/blood-2003-05-1670.
25. Secco, M., Zucconi, E., Vieira, N., Fogacaa, L. L. Q., Cerqueira, A., Carvalho, M. D. F., et al. (2008). Multipotent stem cells from umbilical cord: cord is richer than blood. Stem Cells, 26, 146-150. doi:10.1634/stemcells.2007-0381.
26. Kestendjieva, S., Kyurkchiev, D., Tsvetkova, G., Mehandjiev, T., Dimitrov, A., Nikolov, A., et al. (2008). Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biology International, 32, 724-732. doi:10.1016/j.cellbi.2008.02.002.
27. Fu, Y.-S., Cheng, Y.-C., Lin, M.-Y. A., Cheng, H., Chu, P.-M., Chou, S.-C., et al. (2006). Conversion of human umbilical cord mesenchymal stem cells in Wharton's Jelly to dopaminergic neurons in vitro: potential therapeutic application for parkinsonism. Stem Cells, 24, 115-124. doi:10.1634/stemcells.2005-0053.
28. Montes, M. J., Alemán, P., García-Tortosa, C., Borja, C., Ruiz, C., & García-Olivares, E. (1996). Cultured human decidual stromal cells express antigens associated with hematopoietic cells. Journal of Reproductive Immunology, 30, 53-66. doi:10.1016/0165-0378(96)00954-0.
29. Oliver, C., Cowdrey, N., Abadía-Molina, A. C., & Olivares, E. (1999). Antigen phenotype of cultured decidual stromal cells of human term decidua. Journal of Reproductive Immunology, 45, 19-30. doi:10.1016/S0165-0378(99)00041-8.
30. Heppenstall, R. B., Grislis, G., & Hunt, T. K. (1975). Tissue gas tensions and oxygen consumption in healing bone defects. Clinical Orthopaedics and Related Research, 106, 357-365. doi:10.1097/00003086-197501000-00048.
31. Packer, L., & Fuehr, K. (1977). Low oxygen concentrations extends the lifespan of cultured human diploid cells. Nature, 267, 423-425. doi:10.1038/267423a0.
32. Bialik, S., Cryns, V. L., Drincic, A., Miyata, S., Wollowick, A. L., Srinivasan, A., et al. (1999). The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circulation Research, 85, 403-414.
33. Geng, Y. J. (2003). Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Annals of the New York Academy of Sciences, 1010, 687-697. doi:10.1196/annals.1299.126.
34. Zhu, W. Q., Chen, J. H., Cong, X. F., Hu, S. S., & Chen, X. (2006). Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells, 24, 416-425. doi:10.1634/stemcells.2005-0121.
35. Xu, R. X., Chen, J. H., Cong, X. F., Hu, S. S., & Chen, X. (2008). Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. Journal of Cellular Biochemistry, 103, 256-269. doi:10.1002/jcb.21402.
36. Mylotte, L. A., Duffy, A. M., Murphy, M., O'Brien, T., Samali, A., Barry, F., et al. (2008). Metabolic flexibility permits MSC survival in an ischemic environment. Stem Cells, 26, 1325-1336. doi:10.1634/stemcells.2007-1072.
37. Copland, I. B., Lord-Dufour, S., Cuerquis, J., Legault-Coutu, D., Annabi, B., Wang, E., et al. (2009). Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells, 27, 467-477.
38. Li, W. Z., Ma, N., Ong, L. L., Nesselmann, C., Klopsch, C., Ladilov, Y., et al. (2007). Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 25, 2118-2127. doi:10.1634/stemcells.2006-0771.